169 related articles for article (PubMed ID: 32622394)
1. Ambulatory management of primary spontaneous pneumothorax: an open-label, randomised controlled trial.
Hallifax RJ; McKeown E; Sivakumar P; Fairbairn I; Peter C; Leitch A; Knight M; Stanton A; Ijaz A; Marciniak S; Cameron J; Bhatta A; Blyth KG; Reddy R; Harris MC; Maddekar N; Walker S; West A; Laskawiec-Szkonter M; Corcoran JP; Gerry S; Roberts C; Harvey JE; Maskell N; Miller RF; Rahman NM
Lancet; 2020 Jul; 396(10243):39-49. PubMed ID: 32622394
[TBL] [Abstract][Full Text] [Related]
2. Randomised Ambulatory Management of Primary Pneumothorax (RAMPP): protocol of an open-label, randomised controlled trial.
Hallifax R; Laskawiec-Szkonter M; Dobson M; Gerry S; Miller RF; Harvey JE; Rahman N
BMJ Open Respir Res; 2019; 6(1):e000403. PubMed ID: 31179004
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of ambulatory care management of primary spontaneous pneumothorax: an open-label, randomised controlled trial.
Luengo-Fernandez R; Landeiro F; Hallifax R; Rahman NM
Thorax; 2022 Sep; 77(9):913-918. PubMed ID: 35354647
[TBL] [Abstract][Full Text] [Related]
4. Ambulatory management of secondary spontaneous pneumothorax: a randomised controlled trial.
Walker SP; Keenan E; Bintcliffe O; Stanton AE; Roberts M; Pepperell J; Fairbairn I; McKeown E; Goldring J; Maddekar N; Walters J; West A; Bhatta A; Knight M; Mercer R; Hallifax R; White P; Miller RF; Rahman NM; Maskell NA
Eur Respir J; 2021 Jun; 57(6):. PubMed ID: 33334938
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and medical service use for spontaneous pneumothorax: a 12-year study using nationwide cohort data in Korea.
Kim D; Jung B; Jang BH; Chung SH; Lee YJ; Ha IH
BMJ Open; 2019 Oct; 9(10):e028624. PubMed ID: 31662355
[TBL] [Abstract][Full Text] [Related]
6. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
7. Simple aspiration versus intercostal tube drainage for primary spontaneous pneumothorax in adults.
Carson-Chahhoud KV; Wakai A; van Agteren JE; Smith BJ; McCabe G; Brinn MP; O'Sullivan R
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD004479. PubMed ID: 28881006
[TBL] [Abstract][Full Text] [Related]
8. Conservative versus Interventional Treatment for Spontaneous Pneumothorax.
Brown SGA; Ball EL; Perrin K; Asha SE; Braithwaite I; Egerton-Warburton D; Jones PG; Keijzers G; Kinnear FB; Kwan BCH; Lam KV; Lee YCG; Nowitz M; Read CA; Simpson G; Smith JA; Summers QA; Weatherall M; Beasley R;
N Engl J Med; 2020 Jan; 382(5):405-415. PubMed ID: 31995686
[TBL] [Abstract][Full Text] [Related]
9. Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial.
Stewart S; Ball J; Horowitz JD; Marwick TH; Mahadevan G; Wong C; Abhayaratna WP; Chan YK; Esterman A; Thompson DR; Scuffham PA; Carrington MJ
Lancet; 2015 Feb; 385(9970):775-84. PubMed ID: 25467562
[TBL] [Abstract][Full Text] [Related]
10. Study protocol for a randomised controlled trial of invasive versus conservative management of primary spontaneous pneumothorax.
Brown SG; Ball EL; Perrin K; Read CA; Asha SE; Beasley R; Egerton-Warburton D; Jones PG; Keijzers G; Kinnear FB; Kwan BC; Lee YC; Smith JA; Summers QA; Simpson G;
BMJ Open; 2016 Sep; 6(9):e011826. PubMed ID: 27625060
[TBL] [Abstract][Full Text] [Related]
11. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group
Lancet; 2022 Jan; 399(10320):143-151. PubMed ID: 34800427
[TBL] [Abstract][Full Text] [Related]
12. Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial.
Cools F; Virdone S; Sawhney J; Lopes RD; Jacobson B; Arcelus JI; Hobbs FDR; Gibbs H; Himmelreich JCL; MacCallum P; Schellong S; Haas S; Turpie AGG; Ageno W; Rocha AT; Kayani G; Pieper K; Kakkar AK;
Lancet Haematol; 2022 Aug; 9(8):e594-e604. PubMed ID: 35779560
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous Pneumothorax in Children: National Management Strategies and Outcomes.
Williams K; Oyetunji TA; Hsuing G; Hendrickson RJ; Lautz TB
J Laparoendosc Adv Surg Tech A; 2018 Feb; 28(2):218-222. PubMed ID: 29237135
[TBL] [Abstract][Full Text] [Related]
14. Simple aspiration and drainage and intrapleural minocycline pleurodesis versus simple aspiration and drainage for the initial treatment of primary spontaneous pneumothorax: an open-label, parallel-group, prospective, randomised, controlled trial.
Chen JS; Chan WK; Tsai KT; Hsu HH; Lin CY; Yuan A; Chen WJ; Lai HS; Yang PC
Lancet; 2013 Apr; 381(9874):1277-82. PubMed ID: 23489754
[TBL] [Abstract][Full Text] [Related]
15. Digital versus analogue chest drainage system in patients with primary spontaneous pneumothorax: a randomized controlled trial.
Ruigrok D; Kunst PWA; Blacha MMJ; Tomlow B; Herbrink JW; Japenga EJ; Boersma W; Bresser P; van der Lee I; Mooren K
BMC Pulm Med; 2020 May; 20(1):136. PubMed ID: 32393220
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
17. Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Hanna CR; Blyth KG; Burley G; Carmichael S; Evans C; Hinsley S; Khadra I; Khoo S; Lewsley LA; Jones RR; Sharma R; Taladriz-Sender A; Thomson EC; Scott JT
Trials; 2020 Nov; 21(1):935. PubMed ID: 33213530
[TBL] [Abstract][Full Text] [Related]
18. Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
Butler CC; Yu LM; Dorward J; Gbinigie O; Hayward G; Saville BR; Van Hecke O; Berry N; Detry MA; Saunders C; Fitzgerald M; Harris V; Djukanovic R; Gadola S; Kirkpatrick J; de Lusignan S; Ogburn E; Evans PH; Thomas NPB; Patel MG; Hobbs FDR;
Lancet Respir Med; 2021 Sep; 9(9):1010-1020. PubMed ID: 34329624
[TBL] [Abstract][Full Text] [Related]
19. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
20. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial.
Aujesky D; Roy PM; Verschuren F; Righini M; Osterwalder J; Egloff M; Renaud B; Verhamme P; Stone RA; Legall C; Sanchez O; Pugh NA; N'gako A; Cornuz J; Hugli O; Beer HJ; Perrier A; Fine MJ; Yealy DM
Lancet; 2011 Jul; 378(9785):41-8. PubMed ID: 21703676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
